High-fat feeding stimulates endocrine, glucose-dependent insulinotropic polypeptide (GlP)-expressing cell hyperplasia in the duodenum of Wistar rats

Diabetologia

Volumn 53, Issue 10, 2010, Pages 2233-2240

  Gniuli, D ^a   Calcagno, A ^b   Dalla Libera, L ^b   Calvani, R ^a   Leccesi, L ^a   Caristo, M E ^a   Vettor, R ^b   Castagneto, M ^a   Ghirlanda, G ^a   Mingrone, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Duodenum; Endocrine cell hyperplasia; Glucagon like peptide 1; Glucose dependent insulinotropic polypeptide; High fat diet; Insulin

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; KI 67 ANTIGEN; TRANSCRIPTION FACTOR PDX 1; TRIPALMITIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL AGGREGATION; CELL HYPERPLASIA; CELL SECRETION; CONTROLLED STUDY; DUODENUM MUCOSA; ENTEROENDOCRINE CELL; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; LIPID DIET; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT;

ANALYSIS OF VARIANCE; ANIMALS; AREA UNDER CURVE; BLOOD GLUCOSE; BODY WEIGHT; DIETARY FATS; DUODENUM; ENTEROENDOCRINE CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE TOLERANCE TEST; HYPERPLASIA; IN SITU NICK-END LABELING; INSULIN; INTESTINAL MUCOSA; MALE; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 77958050591     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1830-9     Document Type: Article

References (31)

1. Ohtsubo K, Takamatsu S, Minowa MT, Yoshida A, Takeuchi M, Marth JD (2005) Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell 123:1307-1321
2. Gniuli D, Calcagno A, Caristo ME et al (2008) Effects of a high fat diet exposure during fetal life on type 2 diabetes development in the progeny. J Lipid Res 49:1936-1945
3. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840-846
4. Riccardi G, Giacco R, Rivellese AA (2004) Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 23:447-456
5. Bonnard C, Durand A, Peyrol S et al (2008) Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Invest 118:789-800
6. Flatt PR, Bailey CJ, Kwasowski P, Swanston-Flatt SK, Marks V (1983) Abnormalities of GIP in spontaneous syndromes of obesity and diabetes in mice. Diabetes 32:433-435
7. Bailey CJ, Flatt PR, Kwasowski P, Powell CJ, Marks V (1986) Immunoreactive gastric inhibitory polypeptide and K cell hyperplasia in obese hyperglycaemic (ob/ob) mice fed high fat and high carbohydrate cafeteria diets. Acta Endocrinol (Copenh) 112:224-229
8. Flatt PR, Bailey CJ, Kwasowski P, Swanston-Flatt SK (1990) Effects of diets rich in sucrose, coconut fat and safflowerseed oil on the development of the obese hyperglycaemic (ob/ob) syndrome in mice. Diab Res 13:23-28
9. Ponter AA, Salter DN, Morgan LM, Flatt PR (1991) The effect of energy source and feeding level on the hormones of the entero- insular axis and plasma glucose in the growing pig. Br J Nutr 66:187-197
10. Pederson RA, Brown JC (1976) The insulinotropic action of gastric inhibitory polypeptide in the perfused isolated rat pancreas. Endocrinology 99:780-785
11. McClean PL, Irwin N, Cassidy RS, Holst JJ, Gault VA, Flatt PR (2007) GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet. Am J Physiol Endocrinol Metab 293:E1746-E1755
12. Mortensen K, Petersen LL, Orskov C (2000) Colocalization of GLP-1 and GIP in human and porcine intestine. Ann NYAcad Sci 921:469-472
13. Yasuhara S, Perez ME, Kanakubo E, Yasuhara Y, Shin YS, Kaneki M et al (2000) A skeletal muscle apoptosis after burns is associated with activation of proapoptotic signals. Am J Physiol Endocrinol Metab 279:E1114-E1121
14. Gniuli D, Dalla Libera L, Caristo ME, Calvani R, Castagneto M, Mingrone G (2008) High saturated-fat diet induces apoptosis in rat enterocytes and blunts GIP and insulin-secretive response to oral glucose load. Int J Obes (Lond) 32:871-874
15. Jones IR, Owens DR, Moody AJ, Luzio SD, Morris T, Hayes TM (1987) The effects of glucose-dependent insulinotropic polypep- tide infused at physiological concentrations in normal subjects and type 2 (non-insulin- dependent) diabetic patients on glucose tolerance and B cell secretion. Diabetologia 30:707-712
16. Toft-Nielsen MB, Damholt MB, Madsbad S et al (2001) Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab 86:3717-3723 (Pubitemid 32755966)
17. Vilsbøll T, Knop FK, Krarup T et al (2003) The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype. J Clin Endocrinol Metab 88:4897-4903
18. World Health Organization (2007) Obesity and overweight. Available from www.who.int/mediacentre/factsheets/fs311/en/index.html, accessed 1 June 2010
19. Pick A, Clark J, Kubstrup C et al (1998) Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat. Diabetes 47:358-364
20. Asghar Z, Yau D, Chan F, LeRoith D, Chan CB, Wheeler MB (2006) Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes. Diabetologia 49:90-99
21. Rubino F, Gagner M, Gentileschi P et al (2004) The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 240:236-242
22. Guz Y, Montminy MR, Stein R et al (1995) Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium, and pancreatic exocrine and endocrine progenitors during ontogeny. Development 121:11-18
23. Miller CP, McGehee RE Jr, Habener JF (1994) IDX-1: a new homeodomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene. EMBO J 13:1145-1156
24. Jepeal LI, Fujitani Y, Boylan MO, Wilson CN, Wright CV, Wolfe MM (2005) Cell-specific expression of glucose-dependent- insulinotropic polypeptide is regulated by the transcription factor PDX-1. Endocrinology 146:383-391
25. Offield MF, Jetton TL, Labosky PA et al (1996) PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122:983-995
26. Larsson LI, Madsen OD, Serup P, Jonsson J, Edlund H (1996) Pancreatic-duodenal homeobox 1: role in gastric endocrine patterning. Mech Dev 60:175-184
27. Jonsson J, Carlsson L, Edlund T, Edlund H (1994) Insulinpromoter-factor 1 is required for pancreas development in mice. Nature 371:606-609
28. Todoric J, Löffler M, Huber J et al (2006) Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids. Diabetologia 49:2109-2119
29. Fernández-Real JM, Ricart W (1999) Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness. Diabetologia 42:1367-1374
30. Ruhnke M, Ungefroren H, Nussler A etal(2005) Differentiation of in vitro modified human peripheral blood monocytes into hepatocyte- like and pancreatic islet-like cells. Gastroenterology 128:1774-1786
31. Kojima H, Nakamura T, Fujita Y et al (2002) Combined expression of pancreatic duodenal homeobox 1 and islet factor 1 induces immature enterocytes to produce insulin. Diabetes 51:1398-1408